Group items tagged

High prevalence of cancer is expected to aid in growth of the monoclonal antibody therapeutics market. According to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Monoclonal immunotherapy is a successful form of immunotherapy, which makes use of monoclonal antibodies to bind to a specific antigen in cells which are specific to that disease.

Follicular lymphoma is the second most regular non-Hodgkin lymphoma representing around 10-20% of all lymphomas in western nations. The middle age at conclusion is 60 years of age.